Roche agrees to buy Philadelphia biotech Spark Therapeutics for $4.8 billion
Spark Therapeutics Inc., founded by researchers from Children's Hospital of Philadelphia, has agreed to be sold to Switzerland-based Roche Holding AG for $4.3 billion, the Universi…
